ATEROMA 20 MG COM REV CT BL AL/AL X 10
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1037202630050 -
GGREM
542615060004503 -
Código de barras
7898943707062
O que a fonte publica
- Detentor do registro
- SUPERA FARMA LABORATÓRIOS S.A
- Princípios ativos
- ATORVASTATINA CÁLCICA
- Embalagem
- 20 MG COM REV CT BL AL/AL X 10
- Tipo de produto
- Similar
- Classe terapêutica
- C10A1 - ESTATINAS, INIBIDORES DA REDUTASE HMG-CoA
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "ATEROMA 20 MG COM REV CT BL AL/AL X 10",
"holder": "SUPERA FARMA LABORATÓRIOS S.A",
"stripe": null,
"barcodes": [
"7898943707062"
],
"confaz87": true,
"currency": "BRL",
"marketed": null,
"ggremCode": "542615060004503",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "43.312.503/0001-05",
"priceRegime": "Regulado",
"productName": "ATEROMA",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "20 MG COM REV CT BL AL/AL X 10",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "20.70",
"icms-12": "23.52",
"icms-17": "24.94",
"icms-18": "25.24",
"icms-19": "25.56",
"icms-20": "25.88",
"icms-21": "26.20",
"icms-22": "26.54",
"icms-23": "26.88",
"icms-17.5": "25.09",
"icms-19.5": "25.71",
"icms-20.5": "26.04",
"icms-22.5": "26.71",
"icms-12-alc": "23.24",
"icms-17-alc": "24.64",
"icms-18-alc": "24.94",
"icms-19-alc": "25.25",
"icms-20-alc": "25.56",
"icms-21-alc": "25.89",
"icms-22-alc": "26.22",
"icms-23-alc": "26.56",
"withoutTaxes": "20.45",
"icms-17.5-alc": "24.79",
"icms-19.5-alc": "25.41",
"icms-20.5-alc": "25.73",
"icms-22.5-alc": "26.39"
},
"pisCofinsList": "Positiva",
"substanceText": "ATORVASTATINA CÁLCICA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "28.53",
"icms-12": "32.42",
"icms-17": "34.38",
"icms-18": "34.79",
"icms-19": "35.23",
"icms-20": "35.67",
"icms-21": "36.11",
"icms-22": "36.58",
"icms-23": "37.05",
"icms-17.5": "34.58",
"icms-19.5": "35.44",
"icms-20.5": "35.89",
"icms-22.5": "36.82",
"icms-12-alc": "32.13",
"icms-17-alc": "34.06",
"icms-18-alc": "34.48",
"icms-19-alc": "34.91",
"icms-20-alc": "35.34",
"icms-21-alc": "35.79",
"icms-22-alc": "36.25",
"icms-23-alc": "36.72",
"withoutTaxes": "28.27",
"icms-17.5-alc": "34.27",
"icms-19.5-alc": "35.13",
"icms-20.5-alc": "35.57",
"icms-22.5-alc": "36.48"
},
"invalidBarcodes": [],
"activeSubstances": [
"ATORVASTATINA CÁLCICA"
],
"therapeuticClass": "C10A1 - ESTATINAS, INIBIDORES DA REDUTASE HMG-CoA",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1037202630050",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "C10A1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:542615060004503"